Preferred Name |
tinidazole |
|
Synonyms |
Simplotan |
|
Definitions |
A 5-nitroimidazole derivative with antiprotozoal property. Although the mechanism of action has not been fully elucidated, it has been suggested that tinidazole is metabolized and yields nitrite anions and metronidazole. Metronidazole's nitro group in turn is reduced via the parasite ferredoxin, thereby generating a series of free nitro radicals including nitro anions. Toxicity is achieved via depletion of sulfhydryl groups and DNA strand breaks with multiple hits having an additive effect and ultimately leading to cell death. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C890" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C890" NCI Thesaurus) |
|
ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000043288 |
|
altLabel |
Simplotan Fasigyn TDZ Tindamax |
|
CAS Registry |
19387-91-8 |
|
Component of | ||
cui |
C1601334 C2350048 C0040263 C0591480 |
|
definition |
A 5-nitroimidazole derivative with antiprotozoal property. Although the mechanism of action has not been fully elucidated, it has been suggested that tinidazole is metabolized and yields nitrite anions and metronidazole. Metronidazole's nitro group in turn is reduced via the parasite ferredoxin, thereby generating a series of free nitro radicals including nitro anions. Toxicity is achieved via depletion of sulfhydryl groups and DNA strand breaks with multiple hits having an additive effect and ultimately leading to cell death. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C890" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C890" NCI Thesaurus) |
|
Legacy PDQ ID |
7801 |
|
LT |
TRD |
|
NCI ID |
C890 |
|
notation |
CDR0000043288 |
|
ORIG STY |
Drug/agent |
|
prefLabel |
tinidazole |
|
tui |
T109 T195 T121 |